SecBot SecBot

SUPPORT for Patients and Communities Reauthorization Act of 2025

S. 2121 Sen. Bill Cassidy (R-LA) In committee
  1. Introduced Jun 18
  2. Committee Jun 18
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jun 18, 2025Next: Senate vote
496d ago Jun 18, 2025: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 2 filings
Member trades
1trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Medical Devices & Healthcare 1
Search all 1 companies, their asks and price moves Subscribe

Summary

SUPPORT for Patients and Communities Reauthorization Act of 2025

Full summary6 paragraphs

This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.

For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to

• addressing substance use disorders with respect to pregnant and postpartum women, • prevention and recovery from substance use disorders for youth, • housing for individuals in recovery from substance use disorders, • community organizations facilitating recovery from substance use disorders, • loan repayment for certain health care providers treating substance use disorders, • prevention of overdoses of controlled substances, • treatment of children experiencing psychological trauma, and • mental and behavioral health education and training for medical and allied health students.

Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.

Additionally, the bill establishes new requirements for HHS, including requirements relating to

• protecting the National Suicide Prevention Lifeline program from cybersecurity threats, • establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and • reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.

Library of Congress summary, Jun 18, 2025

Summary versions
  • Introduced in SenateJun 18, 2025

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.